[The cutting-edge of medicine anti-MRSA agents; how to select and how to use]

Nihon Naika Gakkai Zasshi. 2012 Apr 10;101(4):1085-91. doi: 10.2169/naika.101.1085.

[Article in Japanese]

Author

Yoshihito Niki¹

Affiliation

¹ Department of Clinical Infectious Diseases, Showa University, School of Medicine, Japan.

PMID: 22730740
DOI: 10.2169/naika.101.1085

No abstract available

Publication types

Review

MeSH terms

Acetamides / therapeutic use
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents / therapeutic use
Cross Infection / drug therapy
Daptomycin / therapeutic use
Dibekacin / analogs & derivatives
Dibekacin / therapeutic use
Humans
Linezolid
Methicillin-Resistant Staphylococcus aureus / drug effects*
Oxazolidinones / therapeutic use
Staphylococcal Infections / drug therapy*
Teicoplanin / therapeutic use
Vancomycin / therapeutic use

Substances

Acetamides
Anti-Bacterial Agents
Anti-Infective Agents
Oxazolidinones
Dibekacin
Teicoplanin
Vancomycin
arbekacin
Linezolid
Daptomycin